Search

everythinglearnresearchcommunity

for

Search:↓

People with late-stage HIV-1 often experience a specific type of hair loss linked to multiple factors, including nutritional issues and immune responses.

Early stage bald spots are linked to skin inflammation and damage to the upper part of the hair follicle.

Animal models have helped understand hair loss from alopecia areata and find new treatments.

Damaged hair follicle stem cells can cause permanent hair loss, but understanding their role could lead to new treatments.

Mice are useful for researching human hair loss and testing treatments, despite some differences between species.

Hair transplants can effectively treat hair loss from CCCA in African American women if there's no inflammation.

Daily use of antifungal shampoo can hide symptoms and make it hard to diagnose fungal scalp infections.

Cytotoxic T cells cause hair loss in chronic alopecia areata.

A 19-year-old male had two rare skin conditions causing scarring and permanent hair loss.

Bexarotene gel shows promise as a new treatment for alopecia areata.

A boy developed a rare skin condition after recovering from a severe skin reaction, and it improved with lotion treatment.

Syphilitic alopecia is a rare hair loss condition in secondary syphilis that looks similar to another condition but can be diagnosed with specific tests and responds to antibiotics.

Alopecia areata causes patchy hair loss and involves immune system disruptions.

Demodex mites rarely cause scalp infections leading to hair loss, but when they do, treatment is effective.

Horizontal scalp biopsy sections are better for diagnosing alopecia areata, showing fewer hair follicles and more miniaturized hairs.

The document concludes that immune system abnormalities cause alopecia areata, but the exact process is still not completely understood.

Two mouse mutations cause similar hair loss despite different skin changes.

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.

The study found that immune responses disrupt hair growth cycles, causing hair loss in alopecia areata.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

The document describes how to tell different types of non-scarring hair loss apart by looking at hair and scalp tissue under a microscope.

Skin grafts on mice can cause an immune response leading to hair loss, useful for studying human hair loss conditions.

ZD1839, a cancer drug, can cause mild skin rashes that are treatable without stopping the medication.

The document explains various skin conditions and their treatments.

Both mouse and rat models are effective for testing alopecia areata treatments.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Cyclosporin effectively and safely treated skin diseases in three pets with no side effects.

Topical diphencyprone helped regrow hair in mice and rats with a condition similar to human hair loss.

A man with a weakened immune system was diagnosed with a rare skin condition called trichodysplasia spinulosa using skin examination techniques.

The study concludes that regulating apoptosis could lead to new treatments for various skin and hair conditions.